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A Fatal Mitochondrial Disease Is Associated
with Defective NFU1 Function in the Maturation
of a Subset of Mitochondrial Fe-S Proteins
Aleix Navarro-Sastre,1,2,14 Frederic Tort,1,2,14 Oliver Stehling,3,14 Marta A. Uzarska,3,14
Jose´ Antonio Arranz,4 Mireia del Toro,5 M. Teresa Labayru,6 Joseba Landa,7 Aida Font,1,2
Judit Garcia-Villoria,1,2 Begon˜a Merinero,2,8 Magdalena Ugarte,2,8 Luis Gonzalez Gutierrez-Solana,9
Jaume Campistol,2,10 Angels Garcia-Cazorla,2,10 Julian Vaquerizo,11 Encarnacio´ Riudor,4 Paz Briones,1,2,12
Orly Elpeleg,13 Antonia Ribes,1,2,15,16,* and Roland Lill3,15,*
We report on ten individuals with a fatal infantile encephalopathy and/or pulmonary hypertension, leading to death before the age of
15 months. Hyperglycinemia and lactic acidosis were common findings. Glycine cleavage system and pyruvate dehydrogenase complex
(PDHC) activities were low. Homozygosity mapping revealed a perfectly overlapping homozygous region of 1.24 Mb corresponding to
chromosome 2 and led to the identification of a homozygous missense mutation (c.622G>T) in NFU1, which encodes a conserved
protein suggested to participate in Fe-S cluster biogenesis. Nine individuals were homozygous for this mutation, whereas one was
compound heterozygous for this and a splice-site (c.545þ5G>A) mutation. The biochemical phenotype suggested an impaired activity
of the Fe-S enzyme lipoic acid synthase (LAS). Direct measurement of protein-bound lipoic acid in individual tissues indeed showed
marked decreases. Upon depletion of NFU1 by RNA interference in human cell culture, LAS and, in turn, PDHC activities were largely
diminished. In addition, the amount of succinate dehydrogenase, but no other Fe-S proteins, was decreased. In contrast, depletion of the
general Fe-S scaffold protein ISCU severely affected assembly of all tested Fe-S proteins, suggesting that NFU1 performs a specific function
in mitochondrial Fe-S cluster maturation. Similar biochemical effects were observed in Saccharomyces cerevisiae upon deletion of NFU1,
resulting in lower lipoylation and SDH activity. Importantly, yeast Nfu1 protein carrying the individuals’ missense mutation was func-
tionally impaired. We conclude that NFU1 functions as a late-acting maturation factor for a subset of mitochondrial Fe-S proteins.Iron-sulfur cluster (ISC) biogenesis is a complex process
involving at least 25 components in mitochondria and
cytosol.1–3 The precise function of the mitochondrial ISC
assembly protein NFU1 is unknown, the more so because
its depletion in yeast is associated with comparatively
weak defects of mitochondrial Fe-S proteins.4,5 Here, we
identified ten individuals with mutations in NFU1 (MIM
608100) and a fatal mitochondrial disease displaying the
biochemical features associated with a defect in lipoic
acid synthesis.6 This co-factor is synthesized by the Fe-S
enzyme lipoic acid synthase (LAS). A LAS defect caused
by impaired Fe-S cluster biogenesis might explain the
biochemical phenotype of low lipoic acid content.
Ten individuals from nine unrelated Spanish families
were born at term and developed normally throughout
the early neonatal period. First symptoms started at age
1–9 months, and all the individuals died on or before the
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656 The American Journal of Human Genetics 89, 656–667, Novembwere failure to thrive, pulmonary hypertension, and
neurological regression (Table 1). However, a detailed clin-
ical presentation and evolution allowed us to classify them
into three groups. The first group included P1 to P3, pre-
senting with failure to thrive and neurological involve-
ment (hypotonia and irritability) without pulmonary
hypertension. Brain imaging of P1 showed bilateral white-
matter lesions. Spongiform degeneration, astrogliosis, and
white-matter necrosis with preservation of U fibers were
confirmed at autopsy in all three individuals. P1 and P2
were siblings and had an unaffected sister, whereas P3 had
a brother who died at the age of 2 months of untreatable
metabolic acidosis. However, biological material was
not available for study. The second group consisted on indi-
viduals P4 and P5, who were diagnosed of pulmonary
hypertension, and after a febrile illness both exhibited
neurological regression. P4 was born to first-degree consan-
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Table 1. Relevant clinical and biochemical data of individuals carrying mutations in NFU1
P1 P2 P3 P4 P5 P6 P7 P 8 P9 P10
Clinical Data
Gender female female female male female male female female female male
Family antecedents Sibling of
patient 2
Sibling of
patient 1
Affected
sibling
Consanguineous
parents.
Affected sibling
NO NO NO NO NO NO
Age at presentation/
age at death
9 m/13m 4 m/10m 5 m/12m 5 m/15m 7 m/8m 2 m/6m 4 m/15m 6m/7m 4m/5m 1m 25d/2 m
Clinical presentation failure to thrive,
psychomotor
retardation,
neurological
regression
failure to thrive,
psychomotor
retardation,
neurological
regression
failure to thrive,
neurological
regression
neurological
regression,
pulmonary
hypertension
neurological
regression,
pulmonary
hypertension
failure to thrive,
pulmonary
hypertension
failure to thrive,
Mild psychomotor
retardation,
pulmonary
hypertension
pulmonary
hypertension
pulmonary
hypertension
failure to thrive,
pulmonary
hypertension.
Dysmorphia
Brain imaging Leukodystrophy
and semioval
necrosis
ND ND ND semioval center
and cerebellum
lesions
ND cerebral atrophy ND ND normal
cranial US
Biochemical Data: Lactate
Plasma (0.5-2uM) 5 4.5 10 4.5 5.5 12 1.8 3.3 2.1 2.0
CSF (0.8-2.8 uM) 3.4 3.7 7 ND ND ND ND ND ND 4.7
Biochemical Data: Glycine
Plasma (CV:81-436 uM) 641 391 706 276 874 656 1500 1920 1137 758
Urine
(CV:110-356 mmol/mol
creatine)
2534 556 857 696 3542 2206 ND ND ND 2282
CSF (CV:3.7-8 uM) 21 49 55 ND ND 20 34 ND 22.7 30
CSF/plasma (<0.04) 0.03 0.12 0.08 ND ND 0.03 0.02 ND 0.02 0.06
Biochemical Data: Alpha-amino-adipate
Urine (CV:<25 mmol/mol
creatine)
78 54 354 105 414 129 High High High 100
Biochemical Data: PDHC
Activity in fibroblastsa 0.095 0.6b 0.13 0.08 ND ND 0.03 0.03 0.002 ND
Biochemical Data: GCS
Activity in liver necropsyc ND ND ND ND 11% 8% ND Undetectable 7% 5%
ND, not determined.
a PDHC (pyruvate dehydrogenase complex) activity is expressed as nmol/min.mg prot; control mean value5 standard deviation: 0.70 5 0.26.
b PDHC activity measured in muscle biopsy (control mean value 5 standard deviation: 1.61 5 0.74).
c GCS (glycine cleavage system) activity is expressed as the percentage of the lowest control value.
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A Figure 1. Biochemical and Genetic Character-
ization of Individuals
(A) Characteristic urine organic acid profile of an
affected individual compared with an age-
matched control. Samples were analyzed by gas
chromatography-mass spectrometry, and peaks
were identified as lactic acid (LA), fumaric acid
(FA), glutaric acid (GA), tyglylglycine (TG),
2-hydroxyglutaric acid (2HGA),2-ketoglutaric acid
(2KGA), 2-hydroxyadipic acid (2HAA), and
2-ketoadipic acid (2KAA). IS is the internal stan-
dard (undecanoic acid). LA, FA, 2HGA, and TG
were not always increased. Quantitative data
from five individuals are presented in Table S1.
(B) Sequence analysis of NFU1 in genomic DNA
shows the homozygous and heterozygous
c.622G>T nucleotide substitution. RFLP analysis
of family 1 shows the c.622G>T substitution in
two affected siblings (P1 and P2) and in their
heterozygous parents (F1) (right panel). Arrows
indicate restriction sites for BstNI in both wild-
type (WT) and mutant NFU1. The length of the
restriction fragments is indicated in the boxes in
the top panel.
(C) Multi-sequence alignment of the conserved
part of NFU1 protein from man and other in-
dicated eukaryotes. The c.622G>T substitution
identified in ten NFU1 individuals replaces a
conserved glycine with a cysteine at position
208 of the protein (p.Gly208Cys). The conserved
Fe-S cluster binding motif CXXC is indicated.clinical phenotype. Autopsy was not performed in these
individuals. The third group comprised P6–P10; pulmonary
hypertension was the main clinical feature in this group
and was accompanied by failure to thrive in three individ-
uals. Among these five individuals, only P7 had mild
psychomotor retardation and recurrent hypoglycemia.
Despite the absence of specific neurological symptoms in
this group, areas of white-matter demyelination, vacuoliza-658 The American Journal of Human Genetics 89, 656–667, November 11, 2011tion, and astrogliosis in the central nervous
system were found in all the cases in which
autopsywas performed. Pulmonary samples
of individuals P7, P8, and P9 showed
obstructive vasculopathy with involvement
of proximal and acinar arteries.
The biochemical phenotype included
metabolic acidosis with variable lactic acide-
mia and hyperglycinemia (Table 1). All
individuals had high urinary excretion of
2-ketoglutaric, 2-ketoadipic, 2-hydroxya-
dipic, and glutaric acids, among others
(Figure 1A and Table S1, available online);
the excretion of glutaric acid was pro-
bably due to spontaneous decarboxylation
of 2-ketoadipic acid.7 In cases where tissues
were available, activity of the glycine cleav-
age system (GCS [MIM 238300]) in liver
was low or undetectable. Pyruvate dehydro-
genase complex (PDHC) activity in fibro-
blasts was also low (Table 1), whereas thepartial PDHC reactions catalyzedbypyruvate decarboxylase
(PDH-E1 [MIM 312170]) and dihydrolipoamide dehydroge-
nase (PDH-E3 [MIM 238331]) subunits were normal (not
shown). Dihydrolipoamide acetyl transferase (PDH-E2
[MIM 608770]) activity was not measured, but analysis of
its cDNAsequencedidnot reveal anymutation (not shown).
Finally, the rates of 14C-substrate oxidation (pyruvate,
leucine, and glutamate) by fibroblasts were low (Table 2).
Table 2. Substrate Oxidation and Respiratory-Chain Activities in Individuals Carrying Mutations in NFU1
P1 P2 P3 P4 P7 P8 P9
Substrate Oxidation in Fibroblasts (Expressed as a Percentage of the Parallel Control)
1-14C-Pyruvate - 6% 5% 2% 6% 5% 8%
2-14C-Pyruvate - undetectable 3% 6% - undetectable 0.4%
1-14C-Glutamate - 21% 2% 65% - 25% 17%
1-14C-Leucine - 43% 73% 40% 10% - -
Respiratory-Chain Activities in Frozen Muscle
Complex I þ complex III (CV:60–210 mU/U
citrate synthase)
88 129 230 - - - -
Complex II þ complex III (CV:23–149 mU/U
citrate synthase)
22 34 37 - - - -
Complex IV (CV:600–1300 mU/U citrate
synthase)
770 908 920 - - - -
Citrate synthase (CV:56–176 mU/U citrate
synthase)
136 112 130 - - - -
(-) not determined.The antecedents in these families suggested an auto-
somal-recessive inheritance, and four families were of Bas-
que origin; historical, linguistic, and numerous genetic
studies support the homogeneity of the Basque people,
who are clearly differentiated from other European popula-
tions.8 Therefore, we considered it appropriate to search
for the genetic cause of the disease by linkage analysis in
two of the individuals of Basque origin. Homozygosity
mapping with DNA of P2 and P3 revealed a perfectly over-
lapping homozygous region of 1.24 Mb in both individ-
uals (Figure S1); this region included 97 homozygous
SNP markers, from rs4384823–rs2278791. This region
harbors 22 open reading frames. On the basis of the
individuals’ biochemical phenotype, we focused on two
genes encoding mitochondrial proteins: FAM136A (RefSeq
NM_032822) and NFU1 (RefSeq NM_001002755.1). No
alterations for full-length cDNA of FAM136A were found.
In contrast, sequence analysis of NFU1 identified a homo-
zygousmutation in exon 7 (c.622G>T) for individuals 1–9.
This mutation changed a highly conserved glycine to a
cysteine at position 208 of the protein (p.Gly208Cys) (Fig-
ure 1B). Glycine 208 is close to the Fe-S cluster binding
motif,5 and it is conserved among all species (Figure 1C).
All available parents—including the parents of P6, whose
DNA was not available—and a sister of P1 and P2 were
heterozygous for the mutation. No carriers were identified
in a control group of 220 Spanish alleles (100 of them of
Basque origin). Carrier rate was studied by restriction-
fragment-length polymorphism (RFLP) analysis, which
made use of the fact that the c.622G>T mutation removes
a BstNI restriction site in exon 7 (Figure 1B). Individual 10
(Tables 1 and 2) was compound heterozygous for the
common mutation and a new substitution in the donor
splice site of exon 6 (c.545þ5G>A). Analysis of parents’
DNA confirmed that the mutations were in separate allelesThe American(Figure 2A). RT-PCR showed normal expression of mRNA
(Figure 2B, left panel). Although P10 is compound hetero-
zygous, RFLP analysis showed only expression for the allele
carrying the c.622G>T mutation. The same pattern was
found in P2, which was used as a positive control (Fig-
ure 2B, left panel). Despite the lack of mRNA expression
derived from the c.545þ5G>A mutation, the NFU1
protein levels of this individual were similar to those of
P2 and the control (Figure 2B, right panel). To determine
the effect of the c.545þ5G>A mutation, we cloned exon
6 and the corresponding intronic flanking regions of
both wild-type and mutant NFU1 into an Exontrap System
vector (Mobitec, Go¨ttingen, Germany). COS7 cells trans-
fected with these plasmids were analyzed by RT-PCR and
sequenced with vector-specific primers. Our results
showed that the c.545þ5G>A nucleotide change caused
a defective splicing and skipping of exon 6 (Figures 2C
and S2). These data fit well with the absence of
c.545þ5G>A transcript in muscle of P1 because exon 6
skipping leads to a frameshift. The predicted transcript,
with a premature stop codon at position 172, was probably
degraded by the nonsense-mediated decay mechanism.
Unfortunately, this effect could not be fully demonstrated
because individual cell lines were not available.
The identification of one common mutation in all the
individuals, nine of whom were homozygous and one of
whom was compound heterozygous, and the fact that
four of the families were of Basque origin suggests a founder
effect in this population, but further studies are necessary
to demonstrate it.
NFU1 contains a short segment of 60 amino acid resi-
dues with homology to bacterial NifU, a multi-domain
protein involved in the assembly of Fe-S clusters in the
complex metalloprotein nitrogenase.9 Fe-S clusters are es-
sential cofactors involved in enzymatic reactions (e.g., inJournal of Human Genetics 89, 656–667, November 11, 2011 659
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Figure 2. The c.545þ5G>A Mutation Gener-
ates a Defective Splicing of NFU1
(A) Left panel: RFLP analysis in genomic DNA
shows the heterozygous c.622G>T substitution
in the affected individual (P10) and his father
(F); C indicates a control, and M indicates the
mother. Right panel: sequence analysis identified
a heterozygous c.545þ5G>A nucleotide change
in P10 and his mother.
(B) Left panel: mRNA expression analysis by
RT-PCR and RFLP in muscle tissue. P10 showed
normal mRNA expression. RFLP analysis was
negative for the allele carrying the c.545þ5G>A
mutation, but not for the allele with the
c.622G>T mutation. P2 was used as a control.
Right panel: immunoblot of muscle tissue ex-
tracts showed similar levels of NFU1 protein for
P10, P2, and a control (C). GAPDH was used as
a loading control.
(C) Splicing assay incorporating wild-type and
c.545þ5G>A minigene Exontrap vector system
(Mobitec, Go¨ttingen, Germany). Abbreviatioins
are as follows: Et1, Exontrap exon 1; Et2, Exon-
trap exon 2;NFU1 exon6, exon 6 and the flanking
intronic regions (left panel). RT-PCR using vector-
specific primers in COS7 cells transfected with
these vectors showed a defective splicing as a
consequence of c.545þ5G>A mutation (right
panel).aconitase), electron transfer (e.g., ferredoxins and respira-
tory complexes I, II, and III), and sensing (e.g., of iron by
IRP1).10 Prokaryotic and eukaryotic relatives of NFU1
bind a labile Fe-S cluster in vitro, and hence it has been sug-
gested that these proteins perform a scaffold function for
the assembly of an Fe-S cluster.4,5,11–16 However, the
precise physiological function of the mitochondrial mem-
ber of the NFU1 protein family has hitherto remained
unknown, mainly because the deletion of yeast NFU1 is
associated with only a weak defect of some mitochondrial
Fe-S proteins.4 Double deletion of NFU1 and ISU1, encod-
ing one of the two general scaffold proteins for Fe-S cluster
assembly in yeast mitochondria, is associated with more
severe defects of aconitase and mitochondrial respiratory
complexes, but the exact role of NFU1 and its functional
relation to ISU1 remained unclear. Of particular interest
here is the role of Fe-S clusters as sulfur donors in the syn-
thesis of lipoic acid catalyzed by the radical S-adenosyl-L-
methionine (SAM) enzyme LAS in mitochondria.17 Lipoic
acid becomes covalently attached to specific lysine residues
of four mitochondrial enzymes; the E2 subunits of PDH,
a-ketoglutarate dehydrogenase (a-KGDH), branched-chain
a-ketoacid dehydrogenase (BCKD), and the H protein of660 The American Journal of Human Genetics 89, 656–667, November 11, 2011the GCS. The biochemistry of lipoic acid
synthesis is partially understood. Current
models propose a multistep process in
which octanoic acid conjugated to an acyl-
carrier protein (ACP) is the substrate for
sulfur insertion by LAS, presumably from
one of the two [4Fe-4S] clusters. Lipoylated
ACP acts as an intermediate for lipoylprotein ligases, which transfer lipoic acid to target
proteins.6
The biochemical phenotype of the individuals was
consistent with aberrations in lipoic acid-dependent path-
ways (see above). We therefore analyzed muscle homoge-
nates of three individuals for protein-bound lipoic acid by
immunostaining with a lipoic acid-specific antibody. This
assay directly measures the product of the LAS enzyme. In
agreement with previous results we detected two predomi-
nant proteins of 65 and 50 kDa, corresponding to lipoic
acid-bound PDH-E2 and a-KGDH-E2, respectively.18 The
lipoylated protein levels of PDH-E2 were at least 60%
decreased in the NFU1 individuals as compared to controls
(Figure 3). In contrast, the amounts of PDH-E2 proteinwere
unaltered, strongly suggesting that the decreased levels of
E2 protein-bound lipoic acid were due to defective lipoyla-
tion. As expected, none of these individuals showed any
decrease of NFU1 protein levels (Figure 3). Together, all
our biochemical observations were consistent with an
impairment of lipoic acid biosynthesis inNFU1 individuals,
suggesting thatNFU1 is required for LAS activity.Moreover,
both LAS17 and NFU1 (Figure S3) are predominantly if not
exclusively located in mitochondria.
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Figure 3. A Point Mutation in Human NFU1 Decreases the
Amounts of Protein-Bound Lipoic Acid
(A) Immunostaining of NFU1 in muscle tissue extracts from
a control and individuals carrying a NFU1 mutation. GAPDH
was used as a loading control.
(B) Immunostaining of PDH- and KGDH-bound lipoic acid and
PDH-E2 protein; muscle tissue extracts were used as in (A). GAPDH
was used as a loading control.
(C) Densitometric quantitation shows a marked decrease of lipoic
acid bound to the E2 subunit of PDH in three NFU1 individuals
(P1, P2, and P6), compared to four control (C1–C4) individuals.
Control results are represented as the mean value 5 1 standard
deviation (n ¼ 4). The protein levels of the PDH-E2 subunit did
not change. Anti-NFU1 antisera were raised in rabbits immunized
with recombinant His6-tagged NFU1. Additional antibodies were
directed against GAPDH, protein conjugated-lipoic acid (Calbio-
chem), and PDHc (kindly donated by W. Ruitenbeek, Nether-
lands). The densitometry program IMAGEJ was applied so that
levels of total PDH-E2- and PDH-E2-bound lipoic acid could be
quantified. All values were normalized to GAPDH.To study thepotential role ofNFU1 in Fe-S clustermatura-
tion of LAS, we employed an established cell culture system
to depleteNFU1byRNA interference (RNAi).19,20 HeLa cells
were transfected with a pool of NFU1-specific or scrambled
siRNAs (Dharmacon), and thereafter cells were grown for
3 days before biochemical analyses.We repeated this proce-
dure twice toachieve efficientdepletionofNFU1mRNAand
protein (Figures 4A and 4B). Growth of NFU1-depleted cellsThe Americanwas slightly decreased as compared to mock-treated or
scrambled siRNA controls (Figure S4). Immunoblotting of
cell extracts revealed markedly decreased levels of lipoic
acid bound to the E2 subunits of PDH and a-KGDH as
well as to the H protein of GCS (Figure 4C). Consistent
with these findings, PDHC activity was not detectable after
NFU1depletion for 9days (Figure 4D). In contrast, the levels
and activities of cellular Fe-S proteins, including cytosolic
and mitochondrial aconitases and cytosolic GPAT, were
virtually unchanged. Because defects in Fe-S cluster
assembly result in rapid degradation of the apoproteins,19
these results indicated anormalmaturationprocess (Figures
4C and 4D). Likewise, the activity of cytochrome oxidase
(COX; complex IV) was unaffected upon NFU1 depletion.
Even though this enzyme lacks an Fe-S cluster, synthesis
of its heme A requires the function of the mitochondrial
[2Fe-2S] ferredoxin Fdx2.21 In contrast, both the amount
and activity of succinate dehydrogenase (SDH; complex II)
were more than 5-fold decreased upon NFU1 depletion
(Figures 4C and 4D). Respiratory-chain activities examined
in the available frozen muscle extracts of three NFU1
individuals showed no deficiencies in complexes IþIII and
complex IV. However, the activities of complexes IIþIII
were low, consistentwith a SDHdeficiency in these individ-
uals (Table 2). Together, these results strongly suggest that
NFU1 is specifically required for the maturation of both
LAS and SDH, but it appears to be dispensable for other
tested Fe-S proteins. The functional defect of LAS explains
the defect in lipoic acid biosynthesis.
The in vitro binding of a labile Fe-S cluster to NFU1
proteins from several species led to the suggestion that
NFU1 might act as an Fe-S scaffold protein.5,11,16 However,
it remained unclear whether mitochondrial NFU1 indeed
performs such a role in vivo and what the relation might
be to the major Fe-S scaffold protein ISCU,22 alterations
in which lead to myopathy with exercise intoler-
ance.23,24 To address this issue, we depleted ISCU by
RNAi and examined the effects on the levels and function
of various Fe-S proteins (Figures 5A and 5B). In contrast to
the results for NFU1-depleted cells, the deficiency of ISCU
severely affected cell growth and resulted in hardly any
cell material after the second transfection (Figure S5).
Immunostaining of cell extracts showed a substantial
decrease in the levels of virtually all analyzed Fe-S proteins,
including mitochondrial and cytosolic aconitases, SDH,
and cytosolic GPAT upon depletion of ISCU, probably as
a result of the instability of the respective Fe-S apoproteins
(Figure 5C). Moreover, the levels of the lipoic acid-contain-
ing subunits of a-KGDH, PDH, and GCS were substantially
decreased, suggesting a potential defect in LAS maturation
upon ISCU depletion. Treatment with scrambled siRNAs
was without severe effects. Accordingly, enzyme activities
measured after 3 days of ISCU depletion showed a strong
decrease for PDHC, mitochondrial and cytosolic aconi-
tases, and SDH (Figure 5D). COX activity, as a non-Fe-S
control, was only slightly affected. These findings indicate
that virtually all tested Fe-S proteins were severelyJournal of Human Genetics 89, 656–667, November 11, 2011 661
Figure 4. Depletion of NFU1 in Human Cell Culture Diminishes the Function of Protein-Bound Lipoic Acid and Succinate Dehydro-
genase, but Not That of Other Fe-S Proteins
HeLa cells were transfected three times with a pool of four different NFU1-specific (3 mg each) or scrambled siRNA (12 mg) or were mock
treated. Each transfection was followed by growth of cells for 3 days (d).
(A and B) The efficiency of NFU1 silencing was analyzed by qRT-PCR (A) or SDS-PAGE and immunostaining of NFU1 (B). Actin served as
a loading control.
(C) The effect of NFU1 depletion on other cellular proteins was examined by immunostaining. Abbreviations are as follows: LA-PDH-E2,
lipoic acid bound to pyruvate dehydrogenase E2 subunit; LA-KGDH-E2, lipoic acid bound to a-ketoglutarate dehydrogenase E2 subunit;
lipoic acid bound to H protein (LA-H) of the glycine cleavage system; aconitase, mitochondrial aconitase; IRP1, iron regulatory protein 1;
and GPAT, glutamate phosphoribosylpyrophosphate amidotransferase.
(D) Activities of the indicated enzymes were measured with cell extracts derived after three transfections (growth of 9 days). The values
were normalized to the activities of citrate synthase (CS) or lactate dehydrogenase (LDH), and displayed as a fraction of the values ob-
tained for mock-treated cells. Error bars indicate the relative error, rE (n ¼ 3). COX indicates cytochrome c oxidase. Antibodies were
directed against mitochondrial aconitase (kindly provided by L. Szweda), GPAT (kindly provided by H. Puccio), beta-actin (Santa
Cruz Biotechnology), SDH (30 kDa Fe-S protein subunit, MitoSciences), and IRP1 (clone 295B, kindly provided by R. Eisenstein).impaired by the loss of ISCU function. Hence, the results
support the major role of ISCU as a Fe-S scaffold pro-
tein22 and in turn make a general scaffold function for
NFU1 unlikely. Rather, NFU1 appears to play a more
specific, auxiliary role in the biogenesis of SDH and LAS,
e.g., in the dedicated transfer of a NFU1-bound Fe-S cluster
to these target Fe-S apoproteins.
To better understand the mechanistic role of NFU1 and
to get an initial idea of the functional consequences of
the p.Gly208Cys change in individuals, we took advantage662 The American Journal of Human Genetics 89, 656–667, Novembof the model organism Saccharomyces cerevisiae. Previously,
no specific defects that would allow mechanistic conclu-
sions had been observed upon deletion of yeast NFU14
(see above). Using the information gained from studies
on humans, we analyzed several enzyme activities in
nfu1D yeast cells in which NFU1 was deleted. Although
there was only a small (1.3-fold) decrease in aconitase
and COX activities, we observed substantial (>4-fold)
decreases in SDH and PDH activities, in striking similarity
to the individuals’ phenotype (Figure 6A). To address theer 11, 2011
Figure 5. Depletion of ISCU Results in a General Defect of Fe-S Proteins and a Deficiency in Protein-Bound Lipoic Acid
HeLa cells were transfected twice with a pool of four different ISCU-specific (3 mg each) or scrambled siRNA (12 mg) or were mock treated.
Each transfection was followed by growth of cells for 3 days (d). Error bars indicate the relative error, rE (n ¼ 3).
(A and B) The efficiency of ISCU silencing was analyzed by qRT-PCR (A) or SDS-PAGE and immunostaining of ISCU (B). Actin served as
a loading control.
(C) The effect of ISCU depletion on protein-bound lipoic acid or various cellular proteins was examined by immunostaining. For abbre-
viations see Figure 3C.
(D) The activities of the indicated enzymes were measured and evaluated as in Figure 4D after depletion of ISCU for 3 days. Anti-ISCU
antisera were raised in rabbits immunized with recombinant ISCU.functionality of the mutated NFU1 protein, we introduced
a corresponding p.Gly194Cys mutation into yeast NFU1.
Plasmids encoding wild-type and mutated yeast Nfu1
were transformed into nfu1D cells, and enzyme activities
were recorded. Wild-type Nfu1 was able to restore the
severe enzyme defects of SDH and PDH to normal levels
(Figure 6B). In contrast, Nfu1Gly194Cys conferred onlyThe Americana minor improvement of these activities, demonstrating
that this protein is functionally impaired.
What might be the mechanistic basis of the functional
impairment of Nfu1Gly194Cys? Purified Nfu1 can bind an
Fe-S cluster,5 yet in vivo no such binding was detectable
by 55Fe radiolabeling or immunoprecipitation of Nfu1,
even after overproduction25 (Figure 6C). It has beenJournal of Human Genetics 89, 656–667, November 11, 2011 663
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Figure 6. The Gly208Cys Mutation of Yeast NFU1 Leads to Its
Functional Impairment and Identifies NFU1 as a Late-Acting
Fe-S Transfer Protein
(A) Enzyme activities of mitochondrial aconitase (ACO), respira-
tory complexes II (SDH) and IV (COX), and pyruvate dehydroge-
nase (PDH) were determined relative to malate dehydrogenase
(MDH) in mitochondria isolated from wild-type (WT) and nfu1D
yeast cells cultivated in rich glucose medium. Deletion of NFU1
was confirmed by PCR (not shown) and immunostaining (inset).
Nfu1 was detected between two unspecifically labeled bands.
(B) Yeast nfu1D cells were transformed with overexpression vec-
tors containing no gene (-), the wild-type gene, or the human-
mutation-corresponding Gly194Cys variant of yeast NFU1
(Nfu1G194C). After growth in synthetic glucose-containing me-
dium (SD) lacking uracil, mitochondria were isolated from these
and wild-type (WT) cells. The indicated enzyme activities and
the immunostainingwere performed as in (A). Cells with a deletion
of LIP5 (lip5D) encoding yeast LAS were used as a control.
(C) Wild-type, Gal-NFS1, Gal-ISU1/isu2D (Gal-ISU1), Gal-SSQ1,
Gal-GRX5 and isa1/2D cells overproducing wild-type Nfu1 or
Nfu1G194C were grown in iron-poor SD media. Cells were radiola-
beled with 10 mCi 55Fe for 2 hr, and the overproduced proteins
664 The American Journal of Human Genetics 89, 656–667, Novembreported for ferredoxins or the bacterial Fe-S scaffold
protein IscU that mutations might stabilize the association
of bound Fe-S clusters26,27. We therefore tested Fe-S cluster
binding to mutated Nfu1Gly194Cys and found that it bound
significant amounts of radioactive 55Fe in vivo (Figure 6C).
Binding of 55Fe was dependent on several core members of
the ISC assembly machinery (Nfs1, Isu1, Ssq1, and Grx5),
but not on the late-acting Isa1-2.1,28 This striking result
suggests that the Nfu1Gly194Cys-bound iron is part of an
Fe-S cluster whose synthesis is dependent on both the
major scaffold protein Isu1 and factors releasing the Fe-S
cluster from Isu1 (Ssq1, Grx5).29 Hence, Nfu1 appears to
receive its cluster from Isu1 and act late in Fe-S protein
maturation as a specific Fe-S cluster transfer protein (Fig-
ure 7), a conclusion which nicely fits our observations in
HeLa cells (see above). Together, these results make it
rather unlikely that NFU1 plays a role as an alternative
Fe-S scaffold protein. NFU1 might cooperate with the Isa
proteins and Iba57, for which a function late in the matu-
ration of specific Fe-S proteins containing a [4Fe-4S] cluster
has been shown previously.28,30,31 This newly defined role
of mitochondrial NFU1 late in the Fe-S protein biogenesis
pathway is similar to the assumed function of the mito-
chondrial P loop NTPase IND1, which also transiently
binds an Fe-S cluster and is specifically required for
assembly of respiratory complex I, but not for assembly
of other mitochondrial Fe-S proteins.32,33
Our study has identified disease-causingNFU1mutations
associated with a fatal mitochondrial disease characterized
by biochemical defects in the activity of lipoic acid-
containing proteins. A similar fatal infantile disease with
decreased activities of PDHC and a-KGDH, lactic acidosis,
and hyperglycinemia has previously been described.34 The
defect was located on chromosomal region 2p14-2p13, an
observation that fits well with the NFU1 localization.
However, the three siblings of one of the two families of
this study34 presentedwithneonatal symptoms, in contrast
to the individuals described here, who developed pheno-
types several months after birth. Furthermore, PDH-E1
and complexes I, II, and III of the respiratory chain were
severely deficient in individuals of the other study, whereas
our individuals showed only complex II deficiency. The
observed differences might be due to a more severe muta-
tion within the same gene or caused by a defect in another
gene. Interestingly, the lipoic acid defects seen in cultured
HeLa cells upon NFU1 depletion could not be reverted by
the addition of lipoic acid to themedium (data not shown),
a result consistent with the inability of exogenously
provided lipoic acid to rescue a LAS knockout mouse.35
Our work adds to the list of disorders associated with
ISC-assembly-machinery components such as frataxin,were immunoprecipitated from cell extracts with polyclonal anti-
bodies raised against Nfu1. The amounts of coprecipitated 55Fe
were quantified by scintillation counting. The background ob-
tained for samples with nonspecific antibodies was subtracted.
Error bars indicate the SEM (nR 4).
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Figure 7. A Working Model for the Late-Acting Function of
NFU1 in Mitochondrial Fe-S Protein Biogenesis
The findings of this work suggest a late-acting function of NFU1 in
the pathway of Fe-S (red and yellow circles) protein maturation.
NFU1 is preferentially needed for Fe-S cluster assembly of succi-
nate dehydrogenase (SDH) and lipoic acid synthase (LAS), but
not of other proteins such as aconitase. An NFU1 functional defect
due to a point mutation in the fatal mitochondrial disease
described in this work results in defective SDH and LAS and hence
in decreased synthesis of lipoic acid (LA) and a lack of lipoylation
of the E2 subunits of PDH, a-KGDH, and BCDH and the H protein
of GCS. In contrast to depletion of NFU1, depletion of the major
Fe-S scaffold ISCU affects maturation of virtually all cellular Fe-S
proteins, including cytosolic ones, which additionally need the
CIA machinery for maturation. ISCU, together with the cysteine
desulfurase Nfs1-Isd11 and frataxin, which is depleted in Fried-
reich ataxia, is also required for de novo synthesis of a transiently
bound Fe-S cluster on NFU1. Chaperones and GRX5 may be
involved in Fe-S cluster release from ISCU and transfer to both
NFU1 and target apoproteins. Finally, NFU1 is needed for matura-
tion of specific targets such as LAS and SDH. In this late step, NFU1
may cooperate with IBA57-ISCA1, yet these latter proteins appear
to address most or all mitochondrial target proteins with a [4Fe-4S]
cluster.GRX5, and ISCU23,24,36,37 (Figure 7). Remarkably, NFU1-
deleted yeast cells show wild-type growth rates,4 and like-
wise our NFU1 individuals do not show any conspicuous
phenotype until at least 1 month of age. Apparently, yeast
and human embryonic and neonatal cells can bypass the
requirement for full NFU1 function in the maturation of
SDH and LAS. Both of these latter proteins contain [4Fe-
4S] clusters, which also require the ISC proteins IBA57
and ISCA1 for assembly28,30,38 (Figure 7). Determining
whether these or other (unknown) proteins are responsible
for (partially) taking over the function of NFU1 in yeast
and in the first months of human life will require further
work. It is also possible that individuals after birth face
conditions, e.g., increased oxygen exposure, which require
the specific function of NFU1. Insights into these inter-
esting questions will require a better understanding of
the interaction network of NFU1 and other late-acting
ISC proteins such as ISA and IBA57. Our biochemical
explanation of the NFU1-associated disease phenotype
and the identification of the particular step of NFU1 func-
tion in Fe-S protein biogenesis will be of importance for
both diagnosis and potential treatment of individuals af-
flicted with lipoic acid and Fe-S cluster biogenesis defects.The AmericanAll the procedures with human material were approved
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